Join the Intellectual Property Section of the NCBA for the In-House Counsel Event in Durham. Listen to presentations and enjoy food and drink with your colleagues.
With the Supreme Court’s recent decision in Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), re-directing the legal analysis for Enablement, as well as creating considerations for Written Description, Applicants and Patentees need to re-craft IP strategies for capturing early-stage technologies that functionally claim their invention. Drs. Julie Meigs (Womble Bond Dickinson) and Bernard Brown, II (Michael Best) will offer guidance in the post Amgen v. Sanofi era.
This event is hosted by the In-House Committee of the Intellectual Property Law Section.